Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
1587.HK Stock Summary
Top 10 Correlated ETFs
1587.HK
In the News
1587.HK Financial details
Company Rating
Buy
Market Cap
329.8M
Income
29.53M
Revenue
566.31M
Book val./share
-
Cash/share
-
Dividend
0.02
Dividend %
3.09%
Employees
174
Optionable
No
Shortable
Yes
Earnings
16 Aug 2023
P/E
6.35
Forward P/E
-
PEG
-0.97
P/S
0.42
P/B
0.67
P/C
-
P/FCF
4.95
Quick Ratio
2.18
Current Ratio
4.21
Debt / Equity
0.09
LT Debt / Equity
0
-
-
EPS (TTM)
0.04
EPS next Y
-
EPS next Q
-
EPS this Y
-46.15%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
8.25%
Revenue last 5Y
6.74%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-8.33%
SMA50
-6.78%
SMA100
-12.7%
Inst Own
-
Inst Trans
-
ROA
9%
ROE
11%
ROC
0.14%
Gross Margin
17%
Oper. Margin
9%
Profit Margin
7%
Payout
28%
Shs Outstand
680M
Shs Float
170M
-
-
-
-
Target Price
-
52W Range
0.485-0.72
52W High
-
52W Low
-
RSI
9.73
Rel Volume
8.61
Avg Volume
6.97K
Volume
60K
Perf Week
-14.91%
Perf Month
-20.49%
Perf Quarter
-19.17%
Perf Half Y
-19.17%
-
-
-
-
Beta
0.104
-
-
Volatility
0.03%, 0.03%
Prev Close
-4.9%
Price
0.485
Change
-6.73%
1587.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.88 | 0.85 | 0.96 | 1.27 | 1.07 | |
Net income per share | 0.05 | 0.04 | 0.05 | 0.13 | 0.07 | |
Operating cash flow per share | 0.06 | 0 | 0.07 | -0.03 | 0.14 | |
Free cash flow per share | 0.06 | -0.01 | 0.07 | -0.03 | 0.09 | |
Cash per share | 0.3 | 0.26 | 0.33 | 0.2 | 0.31 | |
Book value per share | 0.46 | 0.45 | 0.5 | 0.61 | 0.66 | |
Tangible book value per share | 0.46 | 0.45 | 0.5 | 0.61 | 0.66 | |
Share holders equity per share | 0.46 | 0.45 | 0.5 | 0.61 | 0.66 | |
Interest debt per share | 0 | 0.01 | 0.01 | 0.04 | 0.04 | |
Market cap | 265.37M | 297.19M | 180.01M | 377.39M | 324.05M | |
Enterprise value | 84.13M | 157.24M | -34.92M | 268.4M | 134.7M | |
P/E ratio | 9.43 | 9.91 | 5.16 | 4.39 | 6.8 | |
Price to sales ratio | 0.5 | 0.51 | 0.27 | 0.44 | 0.44 | |
POCF ratio | 7.88 | -103.8 | 3.81 | -21.9 | 3.43 | |
PFCF ratio | 8.05 | -79.51 | 3.82 | -21 | 5.3 | |
P/B Ratio | 0.97 | 0.98 | 0.53 | 0.91 | 0.72 | |
PTB ratio | 0.97 | 0.98 | 0.53 | 0.91 | 0.72 | |
EV to sales | 0.16 | 0.27 | -0.05 | 0.31 | 0.18 | |
Enterprise value over EBITDA | 1.99 | 3.45 | -0.64 | 2.68 | 1.93 | |
EV to operating cash flow | 2.5 | -54.92 | -0.74 | -15.58 | 1.43 | |
EV to free cash flow | 2.55 | -42.06 | -0.74 | -14.94 | 2.2 | |
Earnings yield | 0.11 | 0.1 | 0.19 | 0.23 | 0.15 | |
Free cash flow yield | 0.12 | -0.01 | 0.26 | -0.05 | 0.19 | |
Debt to equity | 0 | 0.01 | 0.03 | 0.06 | 0.05 | |
Debt to assets | 0 | 0.01 | 0.02 | 0.05 | 0.04 | |
Net debt to EBITDA | -4.3 | -3.07 | -3.96 | -1.09 | -2.71 | |
Current ratio | 5.95 | 4.99 | 5.24 | 3.71 | 4.21 | |
Interest coverage | 48.34 | 112.86 | 66.96 | 90.92 | 118.96 | |
Income quality | 0.82 | -0.07 | 0.96 | -0.16 | 1.44 | |
Dividend Yield | 0 | 0 | 0 | 0.02 | 0.04 | |
Payout ratio | 0 | 0 | 0 | 0.1 | 0.28 | |
Sales general and administrative to revenue | 0.07 | 0.06 | 0.05 | 0.04 | 0.05 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.02 | 0.31 | 0 | 0.04 | -0.35 | |
Capex to revenue | 0 | 0 | 0 | 0 | -0.05 | |
Capex to depreciation | -1.37 | -0.21 | -0.05 | -0.18 | -8.63 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.7 | 0.67 | 0.76 | 1.32 | 1.02 | |
ROIC | 0.11 | 0.1 | 0.1 | 0.17 | 0.1 | |
Return on tangible assets | 0.09 | 0.08 | 0.08 | 0.16 | 0.09 | |
Graham Net | 0.24 | 0.2 | 0.24 | 0.07 | 0.23 | |
Working capital | 271.95M | 299.25M | 333.27M | 313.7M | 312.33M | |
Tangible asset value | 273.33M | 304.05M | 337.26M | 413.8M | 451.42M | |
Net current asset value | 271.95M | 297.81M | 327.52M | 309.14M | 308.35M | |
Invested capital | 0 | 0.01 | 0.03 | 0.06 | 0.05 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 34.34M | 39M | 47.23M | 48.81M | 51.61M | |
Average inventory | 38.33M | 53.99M | 60.54M | 55.97M | 76.47M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 25.85 | 36.31 | 31.15 | 26.04 | 31.48 | |
Days of inventory on hand | 33.07 | 52.68 | 34.56 | 30.75 | 55.84 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 14.12 | 10.05 | 11.72 | 14.02 | 11.6 | |
Inventory turnover | 11.04 | 6.93 | 10.56 | 11.87 | 6.54 | |
ROE | 0.1 | 0.1 | 0.1 | 0.21 | 0.11 | |
Capex per share | 0 | 0 | 0 | 0 | -0.05 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | -116.57M | -108.99M | -132.29M | -189.35M | -125.17M | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.07 | 0.06 | 0.01 | 0.05 | 0.09 | |
Debt to assets | 0.06 | 0.05 | 0.01 | 0.04 | 0.08 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 3.53 | 3.71 | 4.58 | 4.21 | 3.79 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 272.53M | 313.7M | 315.22M | 312.33M | 293.58M | |
Tangible asset value | 371.69M | 413.8M | 427.36M | 451.42M | 454.38M | |
Net current asset value | 268.64M | 309.14M | 311.98M | 308.35M | 291.98M | |
Invested capital | 0.07 | 0.06 | 0.01 | 0.05 | 0.09 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
1587.HK Frequently Asked Questions
What is Shineroad International Holdings Limited stock symbol ?
Shineroad International Holdings Limited is a CN stock and trading under the symbol 1587.HK
What is Shineroad International Holdings Limited stock quote today ?
Shineroad International Holdings Limited stock price is $0.485 today.
Is Shineroad International Holdings Limited stock public?
Yes, Shineroad International Holdings Limited is a publicly traded company.